A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors

NCT06209385 ↗

Phase 1 Completed 14 enrolled Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

The goal of this study is to evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of YZJ-5053 Tablets in Participants with Advanced Solid Tumors

Timeline

Start: 2023-08-11
Primary completion: 2025-04-28
Completion: 2025-07-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	YZJ-5053	Unknown	—	Oral

A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors

Summary

Timeline

Drugs

Indications